|
MediVector is a privately held drug development company. It has created a development platform
that dramatically improves the economics of drug development. MediVector has demonstrated in both the
large pharma and biotech settings that its platform reduces development time and cost by as much as 30% over
industry standards. In addition, the probability of success in the late phases of clinical research is
significantly increased.
We are currently redesigning our website. Please visit us again in the future to learn more. In the meantime, if you need further assistance or information, please contact us at:
MediVector, Inc.
Two International Place, 22nd Floor
Boston, MA 02110
telephone: (617) 439-4500
facsimile: (617) 439-4511
Contact us via email at Information@MediVector.com for more information. |